Search Results - "Osugi, Y."

Refine Results
  1. 1
  2. 2

    Ganciclovir is effective for prophylaxis and treatment of human herpesvirus-6 in allogeneic stem cell transplantation by TOKIMASA, S, HARA, J, MIYAGAWA, H, TANAKA-TAYA, K, YAMANISHI, K, OKADA, S, OSUGI, Y, OHTA, H, MATSUDA, Y, FUJISAKI, H, SAWADA, A, KIM, J. Y, SASHIHARA, J, AMOU, K

    Published in Bone marrow transplantation (Basingstoke) (01-04-2002)
    “…Human herpesvirus 6 (HHV-6) infection and disease are serious complications of allogeneic hematopoietic stem cell transplantation (allo-SCT). Ganciclovir (GCV)…”
    Get full text
    Journal Article
  3. 3

    Hepatocyte Growth Factor Is Constitutively Produced by Human Bone Marrow Stromal Cells and Indirectly Promotes Hematopoiesis by Takai, Kenji, Hara, Junichi, Matsumoto, Kunio, Hosoi, Gaku, Osugi, Yuko, Tawa, Akio, Okada, Shintaro, Nakamura, Toshikazu

    Published in Blood (01-03-1997)
    “…Bone marrow (BM) stromal cells are required for normal hematopoiesis. A number of soluble factors secreted by these cells that mediate hematopoiesis have been…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Human soluble IL-6 receptor: its detection and enhanced release by HIV infection by Honda, M, Yamamoto, S, Cheng, M, Yasukawa, K, Suzuki, H, Saito, T, Osugi, Y, Tokunaga, T, Kishimoto, T

    Published in The Journal of immunology (1950) (01-04-1992)
    “…By using a fluorescence sandwich ELISA for the quantification of soluble human IL-6R, normal human PBMC were found to be induced to release IL-6R into culture…”
    Get full text
    Journal Article
  6. 6

    Thrombotic microangiopathy associated with reactivation of human herpesvirus-6 following high-dose chemotherapy with autologous bone marrow transplantation in young children by MATSUDA, Y, HARA, J, MIYOSHI, H, OSUGI, Y, FUJISAKI, H, TAKAI, K, OHTA, H, TANAKA-TAYA, K, YAMANISHI, K, OKADA, S

    Published in Bone marrow transplantation (Basingstoke) (01-10-1999)
    “…Thrombotic microangiopathy (TMA) is a serious complication of BMT. Several factors are important in the etiology of TMA, such as cyclosporin A, GVHD,…”
    Get full text
    Journal Article
  7. 7

    Deletion mapping of 22q11 in CATCH22 syndrome: identification of a second critical region by Kurahashi, H, Nakayama, T, Osugi, Y, Tsuda, E, Masuno, M, Imaizumi, K, Kamiya, T, Sano, T, Okada, S, Nishisho, I

    Published in American journal of human genetics (01-06-1996)
    “…The deletion at 22q11.2 implicates a variety of congenital anomaly syndromes, for which the acronym CATCH22 has been proposed. Most patients with these…”
    Get full text
    Journal Article
  8. 8

    Inverse relationship between human herpesvirus-6 and -7 detection after allogeneic and autologous stem cell transplantation by MIYOSHI, H, TANAKA-TAYA, K, HARA, J, FUJISAKI, H, MATSUDA, Y, OHTA, H, OSUGI, Y, OKADA, S, YAMANISHI, K

    Published in Bone marrow transplantation (Basingstoke) (01-05-2001)
    “…Human herpesvirus-6 (HHV-6) and -7 were analyzed in 25 and 18 patients with allogeneic (allo) and autologous (auto) stem cell transplantation (SCT),…”
    Get full text
    Journal Article
  9. 9

    Double-conditioning regimens consisting of thiotepa, melphalan and busulfan with stem cell rescue for the treatment of pediatric solid tumors by HARA, J, OSUGI, Y, OKADA, S, OHTA, H, MATSUDA, Y, NAKANISHI, K, TAKAI, K, FUJISAKI, H, TOKIMASA, S, FUKUZAWA, M, OKADA, A

    Published in Bone marrow transplantation (Basingstoke) (01-07-1998)
    “…Major dose-limiting factors of high-dose thiotepa (TEPA) and melphalan are life-threatening mucositis and neurotoxicity. To administer a maximum dose of these…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Juvenile myelomonocytic leukemia relapsing after allogeneic bone marrow transplantation successfully treated with interferon-alpha by OHTA, H, KAWAI, M, SAWADA, A, TOKIMASA, S, FUJISAKI, H, MATSUDA, Y, OSUGI, Y, OKADA, S, HARA, J

    Published in Bone marrow transplantation (Basingstoke) (01-09-2000)
    “…We report a 5-year-old boy with juvenile myelomonocytic leukemia (JMML) which relapsed after an allogeneic bone marrow transplant who was successfully treated…”
    Get full text
    Journal Article
  12. 12

    MALIGNANCIES DEVELOPMENT AFTER PMR AND GCA: PROPENSITY SCORE MATCHED COHORT STUDY by Osugi, Y, Asai, K, Kobayashi, D

    Published in Innovation in aging (16-11-2018)
    “…Background The aim of this study is to evaluate whether polymyalgia rheumatica(PMR) or giant cell arteritis(GCA) is an independent risk factors for…”
    Get full text
    Journal Article
  13. 13

    Allogeneic peripheral stem cell transplantation using positively selected CD34+ cells from HLA-mismatched donors by MATSUDA, Y, HARA, J, YAMANISHI, K, OKADA, S, OSUGI, Y, FUJISAKI, H, TAKAI, K, OHTA, H, NAKANISHI, K, TOKIMASA, S, MIYOSHI, H, TANAKA-TAYA, K

    Published in Bone marrow transplantation (Basingstoke) (01-02-1998)
    “…We examined five children who underwent allogeneic peripheral stem cell transplantation (PSCT) using positively selected CD34+ cells from three or two…”
    Get full text
    Journal Article
  14. 14

    Age‐related changes in surface antigens on peripheral lymphocytes of healthy children by OSUGI, Y., HARA, J., KURAHASHI, H., SAKATA, N., INOUE, M., YUMURA‐YAGI, K., KAWA‐HA, K., OKADA, S., TAWA, A.

    Published in Clinical and experimental immunology (01-06-1995)
    “…SUMMARY The age‐related changes in proportion of various subsets within lymphocytes were investigated in cord blood and peripheral blood from healthy children…”
    Get full text
    Journal Article
  15. 15

    p53 expression in various stages of 4-nitroquinoline 1-oxide induced carcinoma in the rat tongue by Osugi, Y

    “…p53 expression in rat tongue epithelium was investigated immunohistochemically following experimental carcinogenic induction by 4-nitroquinoline 1-oxide…”
    Get more information
    Journal Article
  16. 16

    Myeloid blood CD11c+ dendritic cells and monocyte-derived dendritic cells differ in their ability to stimulate T lymphocytes by Osugi, Yuko, Vuckovic, Slavica, Hart, Derek N.J.

    Published in Blood (15-10-2002)
    “…Dendritic cells (DCs) initiate and direct immune responses. Recent studies have defined different DC populations, therefore we undertook this study comparing 2…”
    Get full text
    Journal Article
  17. 17

    Phase I study of bevacizumab plus irinotecan in pediatric patients with recurrent/refractory solid tumors by Okada, Keiko, Yamasaki, Kai, Tanaka, Chika, Fujisaki, Hiroyuki, Osugi, Yuko, Hara, Junichi

    Published in Japanese journal of clinical oncology (01-11-2013)
    “…Studies have suggested that bevacizumab has shown activity against various pediatric solid tumors. We, therefore, conducted a Phase I study of bevacizumab plus…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Correlation of lining thickness and expression of alpha 2 and alpha 3 integrins within the epithelial lining of odontogenic cysts by Nishimura, A, Ueno, S, Niwa, S, Osugi, Y, Shinoda, Y, Mushimoto, K, Shirasu, R

    Published in Journal of Osaka Dental University (01-10-1998)
    “…Using monoclonal antibodies, we performed immunohistochemical investigations of the expression of alpha 2, alpha 3 and beta 4 integrin subunits within the…”
    Get more information
    Journal Article
  20. 20